Link-Asia International MedTech Group Limited
Link-Asia International MedTech Group Limited, headquartered in Hong Kong, is a prominent player in the medical technology industry, specialising in innovative healthcare solutions. Founded in 2005, the company has established a strong presence across Asia, focusing on the development and distribution of advanced medical devices and diagnostic tools. With a commitment to enhancing patient care, Link-Asia offers a diverse range of products, including cutting-edge imaging systems and minimally invasive surgical instruments. Their unique approach combines state-of-the-art technology with user-friendly designs, setting them apart in a competitive market. Recognised for their excellence, Link-Asia has achieved significant milestones, including partnerships with leading healthcare institutions and a growing portfolio of patents. As a trusted name in MedTech, Link-Asia International MedTech Group Limited continues to drive innovation and improve healthcare outcomes across the region.
DitchCarbon Score
How does Link-Asia International MedTech Group Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Electricity from Other Sources industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Link-Asia International MedTech Group Limited's score of 12 is lower than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Link-Asia International MedTech Group Limited's reported carbon emissions
In 2021, Link-Asia International MedTech Group Limited reported total carbon emissions of approximately 12,505,250 kg CO2e. This figure includes Scope 1 emissions of about 99,700 kg CO2e, which comprise mobile combustion (5,270 kg CO2e) and stationary combustion (94,430 kg CO2e). Scope 2 emissions accounted for approximately 12,505,380 kg CO2e, while Scope 3 emissions were around 12,405,550 kg CO2e. In 2020, the company's total emissions were approximately 7,932,700 kg CO2e, with Scope 1 emissions at about 34,280 kg CO2e and Scope 2 emissions at approximately 7,898,420 kg CO2e. The Scope 3 emissions for that year were also around 7,898,420 kg CO2e. Despite these figures, Link-Asia International MedTech Group Limited has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of documented climate pledges or science-based targets indicates a potential area for improvement in their sustainability strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | |
|---|---|---|
| Scope 1 | 34,280 | 00,000 |
| Scope 2 | 7,898,420 | 00,000,000 |
| Scope 3 | 7,898,420 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Link-Asia International MedTech Group Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
